Search

Get to know Florisela Herrejon Chavez, a cancer biology graduate student in the Gerstner Sloan Kettering School of Biomedical Sciences.

… Wednesday, March 25, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Florisela Herrejon Chavez is a graduate student in the Kharas lab  in the Sloan Kettering Institute. When and

On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “How to Navigate Nation’s Top Hospitals.”

… Thursday, July 22, 2021 On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “ How to Navigate Nation’s Top Hospitals .” The segment positioned MSK as a leader in cancer care while highlighting our specialized care and personal approach and

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Wednesday, November 18, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig Thompson Awarded Columbia Business School’s Deming Cup for Operational Excellence Craig B. Thompson, MD Craig B. Thompson, MD , President and CEO at MSK, was awarded Columbia

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.

… Wednesday, June 19, 2019 Summary MSK researchers identified a new strategy for inhibiting RNA-binding proteins, which play a role in many cancers. Since 2012, Memorial Sloan Kettering cancer biologist Michael Kharas has focused on studying a family of proteins called Musashi. These proteins play a role

The findings will lead to more accurate diagnoses and, potentially, to better treatments.

… Friday, July 20, 2018 Summary Experts say the findings about this type of tumor will lead to more accurate diagnoses and, potentially, to better treatments. In recent years, there have been many advances in treating children with cancer, but brain tumors remain a major challenge. For many pediatric brain

Learn about how nutrition experts are helping people with cancer maintain a healthy diet both during and after treatment.

… Wednesday, March 28, 2018 Summary MSK researchers have shown the crucial role that a healthy diet plays in cancer recovery. They are now developing unique ways to help people who are having transplants maintain good nutrition. People who have stem cell and bone marrow transplants face many challenges

An international team of researchers led by Howard Scher, MD, Co-Chair of the Center for Mechanism Based Therapy and Head of the Biomarker Development Initiative at Memorial Sloan Kettering Cancer Center (MSK), has validated a biomarker that can predict whether people with metastatic castration-resistant prostate cancer (mCRPC) may live longer if they are treated with a taxane-based chemotherapy instead of a second targeted androgen receptor–signaling inhibitor (ARSi).

… Thursday, June 28, 2018 Bottom Line: An international team of researchers led by Howard Scher, MD , Co-Chair of the Center for Mechanism Based Therapy and Head of the Biomarker Development Initiative at Memorial Sloan Kettering Cancer Center (MSK), has validated a biomarker that can predict whether people

With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured.

… Wednesday, May 26, 2021 VIDEO | 00:25 A Developing Mouse Embryo This movie from the Kat Hadjantonakis lab shows an 11-day-old mouse embryo with its internal organs labeled in different fluorescence. The video was prepared by postdoc Evan Bardot. Video Details If you’ve ever explored Google Earth, you

Earlier this year, MSK announced the formation of MSK Ventures, a dedicated venture capital fund which will enable MSK to systematically invest in and help develop, scale, and, in some instances, translate new discoveries and services while diversifying long-term revenue streams. Whitney Snider, MD, joined MSK as Inaugural Managing Partner, after most recently serving as Principle and Vice President of Life Sciences at Alexandria Venture Investments.

… Thursday, March 19, 2026 Earlier this year, MSK announced the formation of MSK Ventures , a dedicated venture capital fund which will enable MSK to systematically invest in and help develop, scale, and, in some instances, translate new discoveries and services while diversifying long-term revenue streams

Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.

… Friday, June 6, 2025 Sometimes doctors say that people don’t die from cancer, they die from metastasis — that is, from the spread of cancer from an initial “primary” tumor to other parts of the body. “We know how to control primary tumors — with surgery, chemotherapy, and radiation,” says physician-scientist